chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous case was reported by a consumer and describes the occurrence of  abdominal discomfort, diarrhea, headache, arm pain and body ache in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient was treated with ALUMINIUM HYDROXIDE GEL, DRIED, MAGNESIUM CARBONATE (ANTICID) at an unspecified dose and frequency. On 08 Jan 2021, the patient experienced headache and arm pain. On 11 Jan 2021, the patient experienced diarrhea and abdominal discomfort. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant product use was not provided by the reporter.
Information has been received from a lawyer regarding a case in litigation concerning a male patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. On or about 16-MAR-2013, the patient was inoculated with the ZOSTAVAX (lot number, dosage and route of administration not provided) at a pharmacy, as recommended for routine adult health maintenance for the prevention of shingles. The ZOSTAVAX did not prevent shingles as intended, and the patient subsequently contracted a persistent strain condition of herpes zoster. On or about 30-SEP-2016, the patient was treated for a blistering vesicular outbreak, which was diagnosed as herpes zoster or shingles. The outcome of the events is unknown. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Initial report was received from a health care professional on 19 January 2012. This case is one of a cluster of seven patients reported by the same reporter who each experienced adverse events following administration of FLUZONE (lot number not reported). The events for the other patients were captured in case numbers 2012-00770, 2012-00771, 2012-00772, 2012-00773, 2012-00774 and 2012-00776. A female patient had received an injection of FLUZONE, sanofi pasteur Inc. (lot number, route, site and date of administration unknown) and an unspecified amount of time later developed diarrhea, red knot at injection site, headaches, body aches, nausea and low grade fever. Illness at the time of vaccination, pre-existing medical conditions and concomitant medications were unknown. It was also unknown if the patient had received any prior doses of influenza vaccine or received any other vaccinations within four weeks prior to FLUZONE. No further information was available at the time of the report. The patient's outcome was recovered. Documents held by sender: none. Follow-up information received from a healthcare professional on 21 February 2012. The patient received an intramuscular left deltoid injection of FLUZONE, sanofi pasteur Inc. lot number UH486AF (reported as invalid lot number UHF486AF), on 07 November 2011 in pm. The patient had severe diarrhea for two days and a hard knot on the left arm at injection site for a week that slowly decreased in size. On 12 November 2011, she had a headache and body ache. On 13 November 2011, she had a headache, body ache and nausea. On 14 November 2011, she had a headache, body ache, nausea and dry heaves. On 15 November 2011, she had a headache, body ache, nausea, dry heaves and then started having diarrhea. She also was vomiting up small amounts of bile and had low grade fevers between 100.1 and 101. The next day was the same. On 17 November 2011, she was back to nausea, diarrhea, and aches all over. On 18 November 2011, she had decreased diarrhea, aches still but less. On 19 November 2011, she just was slightly achy. The outcome remained recovered. No additional information was available. Follow-up information was received on 28 March 2012 from a health care professional. The lot number of FLUZONE was amended to UH486A. No additional information was available at the time of the report. The patient's outcome remained recovered. Documents held by sender: Medical timeline.
Started with complaints about a stomach ache, headache, and tiredness on Saturday. She slept for a couple hours during the day and started to run a temperature in the evening of close to 100 degrees. By Sunday morning, her temperature was over 101 with a slight cough, upper respiratory (runny nose), slight sore throat and felt poorly. Monday and Tuesday, her fever was 102-103. We are now at Tuesday afternoon. She went to the dr. Tuesday a.m. and so far strep is ruled out using a rapid test, awaiting long test results.
Noninjection site zoster-like rash on left abdomen. Red, bumpy, & painful. Resolved within 7 days.
Initial report was received from a health care professional on 04 May 2011. A male patient (age not reported) with no reported past medical history had received on 22 March 2011, a second dose intramuscular injection of IMOVAX Rabies (lot number and site of administration not reported) and two hours later experienced vertigo, nausea and slurred speech that lasted for "about" one hour. On 15 March, the patient had also received the following vaccines: dose one intramuscular injection of IMOVAX Rabies (lot number and site of administration not reported), YF VAX (lot number, route and site of administration not reported) and oral TYPHOID Vaccine (manufacturer and lot number not reported). The patient was evaluated by a physician. Treatments were not reported. No further information was available at the time of the report. The patient's outcome was reported as fully recovered. Documents held by sender: none.
A non-serious spontaneous report of most of the second dose squirted directly into the eye was received from a consumer/non health professional concerning a 5-year-old male. The patient's medical history was not reported. On 21-Nov-2009, the patient received H1N1, Intranasal. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments are not applicable, and the event is considered resolved.
Employee states that she feels pain, warmth, tingling and some times itching at the site.
Itchiness and  hives, hives   as  large  and 4 " inches,  and swollen lips developed next day following  the  vaccine,  03/26/21 around  6  pm, patient  took  Benadryl  2 x 25 mg ,symptoms   diminished but  every  day  patient  develops hives  and a  very  uncomfortable  itchiness throughout  the  entire body  worst  on  upper  extremities  and  torso. On  Monday  03/29/2021, primary  MD  was  notified,   ordered prednisone  10  mg  three  times  a  day  for  three day,  antihistamine  and  referral  to  see  immunologist.
Fatigue, migraine got worse, dizziness, irritability, lightheaded, blood pressure and heart rate went up
Severe soreness in arm for 3-4 days following the shot. After that, a hardness in the arm remained and became itchy on Jan. 27. No other symptoms.
swelling from the injection site up to the left side of neck; fatigue; soreness at injection site; This case was reported by a pharmacist via call center representative and described the occurrence of extensive swelling of vaccinated limb in a 65-year-old female patient who received Herpes zoster (Shingrix) (batch number H549S, expiry date 1st October 2021) for prophylaxis.   On 17th June 2019, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On 17th June 2019, less than a day after receiving Shingrix, the patient experienced fatigue and injection site pain. On 18th June 2019, the patient experienced extensive swelling of vaccinated limb. On an unknown date, the outcome of the extensive swelling of vaccinated limb, fatigue and injection site pain were not recovered/not resolved.   It was unknown if the reporter considered the extensive swelling of vaccinated limb, fatigue and injection site pain to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix on left deltoid and developed fatigue and soreness at the injection site on the same day that she received the vaccine.  The day after receiving the vaccine, patient developed swelling from the injection site  on left deltoid all the way up to the left side of her neck.
Developed hives/rash. Treated with Zyrtec and Pepcid for 7 days. I?m still getting hives 24 hrs after Zyrtec dose. Started a 5 day course of 20mg steroids today.
Initial report received from a physician in the USA on 09/Dec/2005. An 18 year old female patient complained of pain at the injection site with numbness in the arm, pain in left upper chest and right breast with radiation into the back around the dermatome after receiving the injection (route not reported) of Fluzone, lot number U1869AA in the left deltoid on 08/Dec/2005. The patient was seen by the physician and treated with Benadryl and anti-inflammatories. The patient had no illness at the time of immunization. As per reporter, at the time of this report the patient had not recovered.
I had a really sore arm for about a day.  I began not feeling on 03/22/2023 with a scratchy throat. We had just returned home from a cruise. I tested positive for COVID-19 on 03/23/2023. I contacted my doctor and was prescribed seven medications.  I tolerated all my medication with no complications. I previously tested positive for COVID-19 in 04/2022 when I was away. At that time, I contacted my doctor as I would need a letter in order to return home. I ended up self-medicating my symptoms.
Information has been received from a male with "a reaction to a tetanus toxoid shot" where his whole arm swelled up "like a watermelon" who "2 days ago" on 14-OCT-2008 was vaccinated with ZOSTAVAX (Merck), injection and "a couple of hours after getting the vaccine", the injection site was warm, red and swelled up.  The patient was not recovered.  The patient did not seek medical attention.  No further information is available.
This case was reported by a consumer via interactive digital media and described the occurrence of sickness in a female patient who received Men B NVS (Meningococcal B vaccine) for prophylaxis. On an unknown date, the patient received Meningococcal B vaccine at an unknown dose. On an unknown date, less than a year after receiving Meningococcal B vaccine, the patient experienced sickness. On an unknown date, the outcome of the sickness was unknown. It was unknown if the reporter considered the sickness to be related to Meningococcal B vaccine. Additional details were provided as follows: The age at vaccination was not reported. The young patient received Meningococcal B vaccine for college at the reporting time, she could not go. After receiving Meningococcal B vaccine, the patient was too sick to get out of bed, a ruined life.
Received MMR vaccine 2nd dose. Started coughing, wheezing, severe itching, and marked erythema of Sleining cincum and oral cyanosis. Given Epinephrine SC injection, albuterol and inhalation of oxygen.  Sent to ER.
Severe sinus infection, fatigue, joint pain, short memory deficits.    (additional items)
Pt received TD toxoid 0.5 ml im at medical center on 11/10/08 at 4:30 pm. He was transferred here for ETOH detox. At ER here he developed pruritic skin rash noted at 11-23pm, initial VS were OK. He was treated with DECADRON 4 mg im and BENADRYL 50 mg im. Within one hour, he developed hypotension, tachycardia, worsening skin rash. He was given another 4 mg im of DECADRON, IV NSS, EPIPEN 0.3 mg/0.3 ml im with improvement. Comment - On 7/22/08, Pt had TD toxoid without reaction.  12/16/08 Reviewed ER medical records of 11/10/2008. FINAL DX:alleged assault, ETOH intoxication, fall, contusion of forehead & nasal avulsion. Tx w/wound care & Td.  Transferred to higher level of care.  2/18/09 Received Hospital d/c summary of 11/21/-11/24/08. FINAL DX: acute alcohol intoxication; alcohol dependent; personality disorder; DTs; alcoholic liver disease Records reveal patient w/multiple hospitalizations for same.  Improved & d/c to rehab program.
The evening after the shot I had chills and aches. This subsided after 24 hours. In the last two months since the shot, I have had a series of symptoms I?ve never had before including increased heart rate / heart palpitations, easily winded, I have a deep ache in my right arm where I got the shot feels almost in my bone, and I experience chills off and on every few days.
This spontaneous report was received from a registered nurse concerning to an unspecified number of patients of unknown age and gender. Information regarding the patients' medical history, concurrent conditions or concomitant therapy was not provided. On unknown dates, the patients were vaccinated with improperly stored doses of VAQTA (strength, dose, interval and route of administration were not reported) lot number: K005958 with expiration date of: 09-FEB-2017 and lot number: K012457 with expiration date of 04-JUN-2017. No adverse events or product quality complaints (PQC) were reported. This is one of several reports from the same reporter. Additional information has been requested.
I started to feel tingling in my right arm and right hand at 3:45pm.  Shortly after, I began to feel like I was having trouble swallowing.   I immediately took 2 Benadryl tablets.  I called my best friend who is a nurse and is volunteering at Covid Vaccine sites.  She advised me to go park outside my local urgent care in case my symptoms worsened and I needed quick access to an epi-pen, etc.  I drove to the Urgent Care.  I continued to feel that my throat was constricted and could only swallow if I was drinking water through a straw.  I could not swallow on demmand.  I sat outside urgent care for an hour and my symtoms stayed the same for 35 min and then by 60 minutes I felt much better and could swallow without drinking water.
Expired vaccination administered on 10/8/22, when it expired 09/30/22. Per manufacturer, extended stability data supports stability thru 10/19/22.
Patient developed localized swelling in the left arm at vaccine site approximately 2 hours after the vaccine was given.  She developed redness that lasted 24 hours, but the swelling has persisted through October and prompted a medical visit to me on 10/14/21. The swelling improved somewhat from what was noted initially but has not resolved completely.  She has some discomfort in the deltoid area with activities like brushing hair and cutting a bagel, but she does not have disability.  She is able to play lacrosse on her college team and is not bothered by the area during sports.  I have referred her to an upper extremity orthopedist for further evaluation.
After receiving my first dose of the Pfizer vaccine I experienced erratic heartbeats/afib.  It started on Saturday, two days after receiving the shot and I debated on whether to go to the ER.  I ended up seeing my cardiologist the following week but by then was feeling better.  The irregular heartbeats last about 3 days, getting progressively better by the third day, but it was a very slow process.  Obviously very scary since it was pretty severe at first and I didn't know if I was having a cardiac event.
DIARRHEA; FOGGY FEELING; BEING UNABLE  TO FOCUS; COLD AND HOT SWEATS; FINGER NUMBNESS WHICH COMES AND GOES; FEELING DEHYDRATED; BODY WEAK/CAN ONLY LAY IN BED; HEADACHE; SORE IN RIGHT ARM AT INJECTION SITE; This spontaneous report received from a patient concerned a 28 year old male. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included no change in lifestyle. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 207A21A, expiry: 07-AUG-2021) dose was not reported, administered on 15-JUN-2021 for prophylactic vaccination. No concomitant medications were reported. On JUN-2021, treatment medications included: paracetamol. On 15-JUN-2021, the subject experienced diarrhea. On 15-JUN-2021, the subject experienced foggy feeling. On 15-JUN-2021, the subject experienced being unable to focus. On 15-JUN-2021, the subject experienced cold and hot sweats. On 15-JUN-2021, the subject experienced finger numbness which comes and goes. On 15-JUN-2021, the subject experienced feeling dehydrated. On 15-JUN-2021, the subject experienced body weak/can only lay in bed. On 15-JUN-2021, the subject experienced headache. On 15-JUN-2021, the subject experienced sore in right arm at injection site. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from body weak/can only lay in bed, headache, diarrhea, foggy feeling, cold and hot sweats, sore in right arm at injection site, finger numbness which comes and goes, feeling dehydrated, and being unable to focus. This report was non-serious.
Swollen lymph nodes; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558). The reporter is the parent.  A female patient received bnt162b2 (BNT162B2), administration date 05Sep2021 (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (1st dose), for Covid-19 Immunization; Bnt162b2 (2nd dose), for Covid-19 Immunization. The following information was reported: LYMPHADENOPATHY (non-serious), outcome "unknown", described as "Swollen lymph nodes".  Additional Information: She was scheduled to have a mammography on 04Oct and she was calling to see if it's ok for her to go to that appointment."(Further clarification unknown). She developed swollen lymph nodes and she would only give me her name she wouldn't give me her telephone number, address or anything  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
small red circle on arm at injection site; swelling after vaccination; This spontaneous case was reported by a pharmacist and describes the occurrence of VACCINATION SITE ERYTHEMA (small red circle on arm at injection site) and VACCINATION SITE SWELLING (swelling after vaccination) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 03-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (small red circle on arm at injection site) and VACCINATION SITE SWELLING (swelling after vaccination). At the time of the report, VACCINATION SITE ERYTHEMA (small red circle on arm at injection site) and VACCINATION SITE SWELLING (swelling after vaccination) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  Treatment information was not provided.    Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: Follow up was received on 11 may 2021 included additional event
immunization was expired on 05/15/2023 given on 05/25/2023
pt stated that rt arm,rt breast area & rt ax area hurt nearly immed p/vax was & still is painful;states there is sl swelling,moderate heat & small lump in inj site;advised to use cold compress & non-ASA product;did not seek medical attentio
body aches; sore arm; runny stools; fatigue; This is a spontaneous report from non-contactable consumer, the patient via Sales Representative. A 77-year-old male consumer (patient) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot Number: Unknown), via an unspecified route of administration on an unspecified date  as a single dose, for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date the patient experienced body aches, sore arm, runny stools, and fatigue. The clinical outcome of body aches, sore arm, runny stools, and fatigue was unknown.    No follow-up attempts are possible. Information about lot number cannot be obtained. No further information is expected.
stroke on 5/2 8:45 am hospitalized 5 days no physiologiical explanation. 3/4 of right cerebellum is dead. at onset nausea vomiting vision loss, loss of balance and coordination BP bottomed out low heartrate while sleepiing
My headache and nausea started around 10;00pm.  By 11:00 I had chills and abdominal cramps as well.  I had the headache and nausea throughout the night and into the morning, the chills and cramps stopped sometime during the night.  I took Tylenol at 11am.  It helped the headache a little but the nausea continued.  I took Tylenol again at 3:30pm and 9:30pm.  Went to bed at 9:30 and slept until 5:00 am this morning.  I still have a slight headache and a little nausea but feel much better today.
Dizziness, passed out and fell backwards onto tile floor. (FIRST TIME EVER)    Stopped bleeding from cut on back of head.  Severe headache for 3 days. Occasional nausea and lightheadedness.
I developed coughing that I was not doing before. I coughed so much, at one point I had to go to the Emergency room cause my chest became sore from coughing. It's just the coughing. I went to a local Medical Center,
Patient developed a maculopapular rash after 10-15 minutes of administration of vaccine at the clinic.  Patient returned to clinic 6 days later with complaints of myalgia, arthlagia, burning of the skin, chills. Patient took Benadryl OTC prn and Zyrtec.
Massive bloating in stomach, diarrhea, fever, fainting, rash, hives, headache, joint pain in shoulder, abdominal cramps, fatigue, vomiting, nausea. All symptoms happened within first week of first shot.
Intensive itching at injection site, no rash or fever. Pt went for medical follow up. Prescribed benadryl for itching. (red around site)
C/O Pain in frontal sinus onset approximately five (5) minutes after adminstration of FluMist.  Reported the symptoms at 1150 and at this time symptoms at on and off.
Initially there were headaches, different GI issues like diarrhea and heartburn. I wound up having a perforated bowl and went the emergency room.  I was at an urgent care center, and they ran an EKG which was abnormal. There were no issues with my heart but thru a CT scan it was determined that I had a Perforation at Splenic Lecture. I was place on an NPO diet for 2 days along with IV antibiotics. My white blood cell count lowered so my diet was upgraded to clear liquids. On Monday, I was given a full liquid diet for breakfast and soft solids, so I was discharged with 2 oral antibiotics and required to follow a low fiber diet. The antibiotics were for 5 days and the low fiber diet for 2 weeks. There are times that I still get abdominal discomfort still but standing and moving makes it go away. I have seen my primary care doctor to go over everything and I scheduled an appointment to follow up with GI.